Company / Current Assets
Amgen Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$29.1B
FY2025
5-year range
$19.4B / $30.3B
FY2021-FY2025
Trend
+0.1%
vs FY2024
Sector context
#7 of 215
Health Care
What the data says
Among 215 Health Care companies, Amgen is in the top 3% for current assets. Current Assets has fluctuated over the past 10 years, ranging from $18.4B in FY2019 to $49.5B in FY2017.
Based on SEC 10-K filings.
$29.1B in FY2025 with a 5-year CAGR of +6.6%. Top quartile in the Health Care sector.
Declined from $30.3B to $29.1B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +9.4%
- 5-Year CAGR
- +6.6%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 215This company $29.1B Sector average $2.5B
▼
+1047.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +6.6%, indicating consistent growth.
- In FY2025, current assets increased 0.1% year-over-year.
- Ranks #7 out of 215 companies in the Health Care sector.
- Peak current assets was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.1B | +0.1% |
| FY2024 | $29.0B | -4.3% |
| FY2023 | $30.3B | +36.7% |
| FY2022 | $22.2B | +14.4% |
| FY2021 | $19.4B | -8.3% |
| FY2020 | $21.1B | +14.7% |
| FY2019 | $18.4B | -51.0% |
| FY2018 | $37.6B | -24.0% |
| FY2017 | $49.5B | +7.5% |
| FY2016 | $46.0B | +19.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026